AvantiCell products are cell-based assays measuring generic parameters of cell health using sensitive, reproducible fluorescence methodology. AvantiCell's focus on human cancer is illustrated by assays targeting the cellular biology of breast cancer, and backed by many years' research experience in this field. AvantiCell's unique pairing of assays incorporating normal or cancerous cells from the same tissue origin enables an in vitro assessment of potential therapeutic value of candidate drugs and other test materials. Assay products are supplied in kit form, and include cells cryo-preserved in situ in assay plates for “off the freezer shelf” use in your own laboratory with minimal intervention. Cells are supplied together with all the reagents required to conduct the assay. Alternatively, AvantiCell's cell-based analysis can be delivered as a service conducted in-house to clients' specifications and deadlines (see Service Portfolio / Cell-based Screening).

Our portfolio of cell based assays for drug target validation and biomedical research has been developed using AvantiCell's leading-edge cell-based technologies, enabling study of cell function in physiologically-relevant cell culture systems.

E-mail this page to a Colleague